OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and Mode of Action of a Direct Inhibitor of Mycobacterium abscessus InhA
Matthéo Alcaraz, Françoise Roquet-Banères, Stephen Adonai Leon‐Icaza, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 10, pp. 2171-2186
Closed Access | Times Cited: 11
Matthéo Alcaraz, Françoise Roquet-Banères, Stephen Adonai Leon‐Icaza, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 10, pp. 2171-2186
Closed Access | Times Cited: 11
Showing 11 citing articles:
Unlocking InhA: Novel approaches to inhibit Mycobacterium tuberculosis
Simranpreet K. Wahan, Gaurav Bhargava, Viney Chawla, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107250-107250
Closed Access | Times Cited: 7
Simranpreet K. Wahan, Gaurav Bhargava, Viney Chawla, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107250-107250
Closed Access | Times Cited: 7
Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids
Stephen Adonai Leon‐Icaza, Salimata Bagayoko, Romain Vergé, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 8, pp. e1011559-e1011559
Open Access | Times Cited: 12
Stephen Adonai Leon‐Icaza, Salimata Bagayoko, Romain Vergé, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 8, pp. e1011559-e1011559
Open Access | Times Cited: 12
The progress of Mycobacterium tuberculosis drug targets
Xin Zhang, R Zhao, Yao Qi, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 4
Xin Zhang, R Zhao, Yao Qi, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 4
Identification of novel inhibitors targeting Mycobacterium abscessus InhA through virtual screening, docking, and molecular dynamic simulations
M Hasnain Abbas, Abdullah R. Alanzi, Kashif Iqbal Sahibzada, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
M Hasnain Abbas, Abdullah R. Alanzi, Kashif Iqbal Sahibzada, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Computational insights into potential marine natural products as selective inhibitors of Mycobacterium tuberculosis InhA: A structure-based virtual screening study
Manikandan Jayaraman, Vijayakumar Gosu, Rajalakshmi Kumar, et al.
Computational Biology and Chemistry (2023) Vol. 108, pp. 107991-107991
Closed Access | Times Cited: 8
Manikandan Jayaraman, Vijayakumar Gosu, Rajalakshmi Kumar, et al.
Computational Biology and Chemistry (2023) Vol. 108, pp. 107991-107991
Closed Access | Times Cited: 8
New therapeutic strategies for Mycobacterium abscessus pulmonary diseases – untapping the mycolic acid pathway
Matthéo Alcaraz, Thomas E. Edwards, Laurent Kremer
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 8, pp. 813-829
Closed Access | Times Cited: 7
Matthéo Alcaraz, Thomas E. Edwards, Laurent Kremer
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 8, pp. 813-829
Closed Access | Times Cited: 7
In Vitro and In Vivo Efficacy of NITD-916 against Mycobacterium fortuitum
Françoise Roquet-Banères, Matthéo Alcaraz, Claire Hamela, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 4
Open Access | Times Cited: 6
Françoise Roquet-Banères, Matthéo Alcaraz, Claire Hamela, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 4
Open Access | Times Cited: 6
Moles of Molecules against Mycobacterium abscessus: A Review of Current Research
Mario Cocorullo, C Bettoni, Sara Foiadelli, et al.
Future Pharmacology (2023) Vol. 3, Iss. 3, pp. 637-663
Open Access | Times Cited: 3
Mario Cocorullo, C Bettoni, Sara Foiadelli, et al.
Future Pharmacology (2023) Vol. 3, Iss. 3, pp. 637-663
Open Access | Times Cited: 3
Tailoring selective triclosan azo-adducts: Design, synthesis, and anti-mycobacterial evaluation
Shekhar Shekhar, Matthéo Alcaraz, Pule Seboletswe, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22182-e22182
Open Access | Times Cited: 3
Shekhar Shekhar, Matthéo Alcaraz, Pule Seboletswe, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22182-e22182
Open Access | Times Cited: 3
Druggable redox pathways against M. abscessus in cystic fibrosis patient-derived airway organoids
Stephen Adonai Leon‐Icaza, Salimata Bagayoko, Romain Vergé, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Stephen Adonai Leon‐Icaza, Salimata Bagayoko, Romain Vergé, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Cu-promoted synthesis of triclosan-Mannich and Glaser adducts: anti-mycobacterial evaluation with in silico validations
Shekhar Shekhar, Matthéo Alcaraz, Amit Ȧnand, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 10, pp. 949-961
Closed Access
Shekhar Shekhar, Matthéo Alcaraz, Amit Ȧnand, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 10, pp. 949-961
Closed Access
